4 days Ago By ABMN Staff
Russell Investments Group Ltd. raised its stake in shares of Quanterix Co. ( NASDAQ:QTRX – Free Report ) by 19.
8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 401,476 shares of the company’s stock after acquiring an additional 66,315 shares during the period. Russell Investments Group Ltd.
’s holdings in Quanterix were worth $4,268,000 as of its most recent SEC filing. A number of other hedge funds also recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp raised its stake in shares of Quanterix by 1.
8% during the fourth quarter. Bank of New York Mellon Corp now owns 108,186 shares of the company’s stock worth $1,150,000 after purchasing an additional 1,963 shares during the last quarter. Geode Capital Management LLC raised its position in Quanterix by 0.
6% during the 4th quarter. Geode Capital Management LLC now owns 863,503 shares of the company’s stock worth $9,181,000 after buying an additional 4,836 shares during the last quarter. Resona Asset Management Co.
Ltd. acquired a new stake in shares of Quanterix in the 4th quarter worth $55,000. American Century Companies Inc.
boosted its holdings in shares of Quanterix by 9.1% in the fourth quarter. American Century Companies Inc.
now owns 71,992 shares of the company’s stock valued at $765,000 after acquiring an additional 6,023 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Quanterix during the fourth quarter worth about $66,000. 86.
48% of the stock is owned by institutional investors and hedge funds. Analysts Set New Price Targets A number of brokerages have weighed in on QTRX. Scotiabank reaffirmed an “outperform” rating on shares of Quanterix in a report on Tuesday, March 25th.
Canaccord Genuity Group decreased their price target on Quanterix from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th.
Quanterix Trading Down 4.3 % Shares of QTRX opened at $5.36 on Wednesday.
The firm’s 50-day moving average is $6.97 and its two-hundred day moving average is $9.91.
Quanterix Co. has a twelve month low of $4.67 and a twelve month high of $19.
18. The firm has a market capitalization of $207.91 million, a P/E ratio of -5.
06 and a beta of 1.35. Quanterix ( NASDAQ:QTRX – Get Free Report ) last released its quarterly earnings data on Monday, March 17th.
The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.
03). The firm had revenue of $35.16 million during the quarter, compared to analysts’ expectations of $34.
93 million. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.
74%. Analysts predict that Quanterix Co. will post -0.
98 EPS for the current year. About Quanterix ( Free Report ) Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Featured Articles Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. ( NASDAQ:QTRX – Free Report ).
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter ..
